News

Relationship between IOP and scleral response shows promise, says ophthalmologist

A femtosecond laser approach for eyes with low hyperopic presbyopia

Flapless Epi-LASIK has many advantages but flap trimming is another good option when surgeons wish to retain the epithelial sheet

Dr Malugin has come up with a modification of a CTR to be used during MICS surgery

The second part of the primer on the use of stem cells in ophthalmology

A femtosecond laser approach for eyes with low hyperopic presbyopia

Study shows little difference between these forms of endotamponade in patients with PVR

A round up of new products

New performance assessments suggest retinal prothesis augments native vision

Positive pooled results from the MIVI-TRUST phase III programme are a sign that a microplasmin one-off injection will be a real alternative to surgery

Dermatologic, cosmetic technologies studied for benefits in meibomian gland dysfunction

Investigating the best way to directly measure phakic IOLs, why sizing is so critical, potential problems and useful tips to overcome them

Conic intrastomal relaxing incisions can correct difficult types of astigmatism

BiCOM showcased its Diaton tonometer at this year's AAO/MEACO meeting. The pen-like, handheld, portable device can measure eye pressure through the patient's eyelid and over the sclera.

Topcon has launched two new optical coherence tomography (OCT) systems for the International market.

RXi and EyeGate have announced a collaboration focused on non-invasive ocular delivery of RNAi therapeutics. Both companies will contribute technology, expertise and resources to the partnership.

Researchers have found that giving patients a dual therapy of bimatoprost and a beta-blocker is an effective method of lowering intraocular blood pressure (IOP) in patients with open-angle glaucoma.

The Pediatric Cataract Initiative has set a deadline of 15 November for the receipt of applications for its inaugural single small research grant.

Allergan has been given FDA approval for its drug Ozurdex (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation.

ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution.

ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution.

Experience the material-friendly way of marking.

Acucela and Otsuka Pharmaceutical have entered into a definitive agreement for the joint development and promotion of OPA-656, an adenosine A2a receptor agonist under development for treating glaucoma.

Transitions Optical and the US National Council of Negro Women (NCNW) are collaborating to raise awareness about the importance of proper vision care and vision wear among the Africa-American community.

Investigators from The Scripps Research Institute, and Thomas Reh, PhD from the University of Washington, received the highest possible scores for their proposal to investigate the regenerative potential of retinal cells, resulting in a $4.66 million NIH Transformative Award.

AstraZeneca and UCL Institute of Ophthalmology are collaborating to develop regenerative medicines for diabetic retinopathy (DR).

opcon has launched the LENTIS Mplustoric intraocular lens (IOL.

Applied Genetics Technology Corporation (AGTC) has received a grant from the FDA (FDA Orphan Drugs Programme) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease.

A clinical trial is being conducted by the Cornea and Laser Eye Institute (CLEI) into the efficacy and safety of corneal collagen crosslinking (CXL) using riboflavin/dextran and hypotonic riboflavin in patients with progressive keratoconus and corneal ectasia.

OTEurope reports on some of the highlights from the XXVIII Congress of the European Society of Cataract and Refractive Surgeons.